The Champalimaud Foundation's Breast Cancer Research Programme is made up of groups dedicated to all aspects related to the disease, from diagnosis to treatment. The goal is to improve the quality of life and survival of patients by utilising cutting-edge technologies that combine new techniques and methods with clinical practice to better serve patients.

In order for our bodies to efficiently transform into fat the excess carbohydrates we eat, in a process of  “lipogenesis”, two things  must happen. First, the immune system's gamma-delta T cells, a type of lymphocytes that are present in large quantities in adipose tissue (a.k.a. fat), have to produce a substance that triggers lipogenesis, called IL-17.

With nearly 30 presenters—including 4 keynote speakers—ranging from internationally renowned scientists to emerging researchers, the symposium was structured into eight thematic sessions, each exploring different dimensions, from the interplay between tumour cells and their microenvironment to the systemic impacts of cancer on the body.

This 2-day conference organised by the Champalimaud Foundation, in partnership with Faculdade de Motricidade Humana, will provide an overview of the scientific landscape in the area of physical activity and cancer, from prevention to rehabilitation and survivorship.

These are exciting times for research in this space as physical activity becomes more widely recognised as a powerful partner in the prevention and treatment of cancer.

O Centro Clínico Champalimaud pretende admitir um(a) Médico(a) especialista em Dermatologista, para integrar a Unidade de Dermatologia dedicada em exclusividade ao Cancro da Pele.

O Centro Clínico pretende admitir em regime de tempo completo e dedicação plena.

With fully functional inpatient and recovery units, as well as operating rooms, the Centre is now prepared to significantly expand the Champalimaud Foundation's capacity to treat pancreatic cancer patients. With a dedicated team of specialists in the treatment and research of this type of cancer, the Centre's mission is to deliver the highest standard of clinical care.

Natural ageing is one of the main risk factors for cancer. As we become older, the probability of developing cancer increases. This happens, on the one hand, because the probability of acquiring cancer-causing mutations grows as we live longer; and on the other, because our DNA repair mechanisms decline with age.

Host

Carlos Minutti, PhD, Immunoregulation Lab 

Venue

Seminar room